Related Experiment Videos
[Sudden death of cardiac origin]
1Service de Cardiologie A, Hôpital cardiologique, Lille.
Insights
Sudden cardiac death, often caused by ventricular arrhythmias in ischemic heart disease, remains a challenge. Current methods like Holter monitoring and late potentials recording aid risk identification, but drug efficacy for prevention is unproven.
Area of Science:
- Cardiology
- Electrophysiology
Context:
- Sudden cardiac death (SCD) is a major global health concern, with most cases linked to ventricular arrhythmias in ischemic heart disease.
- Ventricular arrhythmias, alongside left ventricular dysfunction, indicate a poor prognosis for patients with heart disease.
Purpose:
- To identify patients at high risk of sudden cardiac death by detecting severe ventricular arrhythmias.
- To evaluate diagnostic methods for predicting sudden cardiac death and assess the effectiveness of antiarrhythmic drug therapy.
Summary:
- Holter monitoring offers valuable quantitative and qualitative arrhythmia data. Programmed electrical stimulation has variable prognostic utility.
- Late potentials recording is a simple, non-invasive method showing promise in identifying complex ventricular arrhythmias and predicting sudden cardiac death risk.
- Despite advances, preventing cardiac sudden death remains difficult, as no epidemiological studies confirm significant mortality reduction through antiarrhythmic drug-induced arrhythmia suppression.
Impact:
- Highlights the need for improved risk stratification tools for sudden cardiac death.
- Underscores the current limitations in effectively preventing sudden cardiac death through pharmacological interventions.
- Emphasizes the ongoing challenge in translating diagnostic advancements into proven preventative strategies for cardiac mortality.
Abstract:
Every minute one patient in the world suddenly dies, of heart disease in the vast majority of the cases. Most of these sudden deaths of cardiac origin are due to ventricular tachycardia and/or fibrillation on a background of ischaemic heart disease. It is now recognized that as much as left ventricular dysfunction these ventricular arrhythmias are of sombre prognosis. To prevent sudden death of cardiac origin, therefore, patients with severe ventricular arrhythmia and consequently at high risk must be identified. Among examinations used for this purpose, the Holter monitoring method is of considerable value as it provides qualitative and, mostly, quantitative information on the arrhythmia. Programmed stimulation--a much more invasive method--has a prognostic value which varies from one author to another. On the other hand, late potentials recording is a simple and innocuous procedure, apparently most reliable as indicator of complex ventricular arrhythmias and sudden death. In spite of all these recent technical advances, the prevention of cardiac sudden death remains problematic since no epidemiological study has yet demonstrated that major reduction or even suppression of ventricular arrhythmias by antiarrhythmic drugs can significantly reduce the coronary mortality rate.